UnknownNot Applicable

Assessment of TRACP-5b in Primary and Secondary Osteoporosis

84 participantsStarted 2021-12-01

Plain-language summary

Assessment of the TRACP-5b level in 1ry OP and 2ry OP such as RA and seronegative spondylitis, that may help in surrogating the use of BMD.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with 1ry OP diagnosed by DXA scan . * Any RA and SpA patients (older than 18 years old), who fulfill the for mentioned diseases criteria with secondary osteoporosis as diagnosed by DXA scan. Exclusion Criteria: * Patients unwilling to participate in the study. * Patients with other autoimmune diseases. * Patients depending on Glucocorticoids with in the last 6 month. * Patients with other causes of 2ry OP (ex. Endocrinal abnormalities, Gastrointestinal diseases, Renal diseases…..etc.)

What they're measuring

Assessment of the TRACP-5b level in 1ry OP and 2ry OP such as RA and seronegative, that may help in surrogating the use of BMD.

Timeframe: Baseline

Trial details

NCT IDNCT05103592

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-01

Contact for this trial

AMIRA MA MANSOUR, Resident

01099777532 am9322729@gmail.com

View on ClinicalTrials.gov More Osteoporosis trials